Through IncyteCARES—a patient support and assistance program for eligible patients prescribed Jakafi, Pemazyre, or Opzelura—we strive to implement initiatives that support patients and remove barriers to accessing these medicines in the U.S. Our team can help patients with understanding their insurance coverage, exploring financial assistance options and providing as-needed support.